siRNAs against PTPN2 are isoform specific. A-G) iMo-DCs were not transfected (NT) or transfected with control siRNAs (siCTRL) or siRNAs against isoforms of PTPN2 (siPTPN2 48kDa or 45kDa) at day 4 and 5 before being collected at day 7 for experiments. A-G) iMo-DCs were lysed in Trizol and RNA was extracted and converted to cDNA. 45kDa PTPN2,48kDa PTPN2 and GAPDH were amplified by A) real-time PCR or B-C) PCR, loaded onto agarose gels and quantified. Representative gels and compilations of at least 4 independent experiments are shown in B) and A) &C) respectively. The data presented are mean±S.E.M. A-C) Significance was established with the Holm-Sidak's one-way analysis of variance. *p<0.05. D-I) iMo-DCs were starved for 5h in RPM1+0.2% BSA, D-H) then lysed. Whole cell lysates were separated by SDS-PAGE, transferred to nitrocellulose membranes and blotted overnight with Abs against D)&F) vinculin and PTPN2 or G)&H) actin and PTPN1. Representative blots and compilation of 4-5 independent experiments are shown. The data presented are mean±S.E.M of normalized protein levels over normalized protein levels of NT cells for E) 48 kDa, 45 isoform or H) PTPN1protein levels or F) ratio of 48 kDa isoform normalized protein levels over 45 kDa normalized protein levels. Significance was established with theTurkey's one-way analysis of variance. *p<0.05. I) Mortality was assayed by Trypan Blue staining. The data presented are mean±S.E.M of the % of Trypan-bluepositive iMo-DCs over total iMo-DCs for at least 6 independent experiments. J)&K) HEK-PAFR were transiently transfected with 48kDa or 45kDa PTPN2 tagged with GFP or left untransfected. Expression levels were determined by flow cytometry using untransfected cells for determination of basal fluorescence. The data presented are mean±S.E.M of G) the % of GFP-positive cells and of H) the Geo Mean value for 7 independent experiments performed in triplicate. Significance was established with paired Student's t-test. L) HEK-PAFR were transiently co-transfected with the hIL-6-luc, control vector (pcDNA3) or phosphatase constructs. Cells were incubated overnight in DMEM-0.2% BSA and stimulated with PAF (100nM) or its vehicle for 6h and luciferase activity was measured. The data presented are a mean±S.E.M of 7-14 independent experiments performed in triplicate. Significance was established with two-way ANOVA with Sidak post-test. *p<0.05.
S-2 Figure. PTPN2 basal phosphatase activity. HEK-PAFR were transfected with Flag-tagged WT or D182A PTPN2 constructs, starved overnight in DMEM 0.2% BSA before being lysed. Immunoprecipitated PTPN2 was incubated with pNPP in PTP assay buffer, OD was taken at different incubation times at 37°C. 4x Laemmli buffer was added. The whole reaction mixture was separated by SDS-PAGE, transferred onto nitrocellulose membrane and incubated overnight with anti-PTPN2 Abs. Normalization of phosphatase activity was done according to the relative levels of PTPN2 detected by Western Blot. A) Representative blot used for normalization of PTP assays. B) Graph represents the phosphatase activity determined by the hydrolysis rate of pNPP by Flag-WT or -D182A PTPN2 isoforms immunoprecipitated from HEK-PAFR. Data are mean±S.E.M for 3 independent experiments. Significance was established with paired two-way ANOVA with Dunnett post-test. S-4 Figure. 48kDa PTPN2 and multiple kinase pharmacological inhibitors do not modulate TNFα-induced IL-6 promoter activity. HEK-PAFR were transiently co-transfected with the hIL-6-luc, the control vector pcDNA3 or the 48 kDa PTPN2 constructs. Cells were incubated overnight in DMEM-0.2% BSA and A) to D) pre-treated for 30 min in DMEM-0.2% BSA with DMSO as vehicle control or A) Jak2 inhibitor AG490 5µM; B) MEK 1 and 2 inhibitor U-0126, 15µM; C) pan PKCs inhibitor GF109203x 2 µM or D) JNK inhibitor SP600125, 5µM. Stimulation was done with TNFα (20 ng/ml) or vehicle for 6h and luciferase activity was measured. The data presented are mean±S.E.M of at least 4 independent experiments performed in triplicate.
S-6 Figure. 48 kDa PTPN2 does not modulate basal PKD or Akt activation in iMoDCs. iMo-DCs were transfected with control siRNAs (siCTRL) or siRNAs against isoforms of PTPN2 (siPTPN2 48kDa or 45kDa) on day 4 and 5 before being collected on day 7 for experiments. iMo-DCs were starved for 5h in RPM1+0.2% BSA, stimulated with EtOH (PAF's vehicle) for 70min, centrifuged and lysed. Whole cell lysates were separated by SDS-PAGE, transferred to nitrocellulose membranes and blotted overnight with Abs against A) pSer473 Akt, Akt and vinculin/actin or B) pSer910PKD, PKD and actin. Compilation of at least 3 independent experiments are shown. The data presented are in a whisker and box graph (Min to Max).
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